These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 6237304

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Platelet taurine in Down's syndrome.
    Boullin DJ, Airaksinen EM, Paasonen MK.
    Med Biol; 1975 Jun; 53(3):184-6. PubMed ID: 125819
    [Abstract] [Full Text] [Related]

  • 4. Catabolism of serotonin in Down's syndrome (tisomy 21).
    Kamoun P, Lafourcade G, Jerome H.
    Biomedicine; 1974 Oct 10; 21(10):426-8. PubMed ID: 4281668
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sodium transport ouabain binding, and (Na+/K+)-ATPase activity in Down's syndrome platelets.
    McCoy EE, Enns L.
    Pediatr Res; 1978 Jun 10; 12(6):685-9. PubMed ID: 149949
    [No Abstract] [Full Text] [Related]

  • 7. Sodium and serotonin uptake into Na+ depleted platelets from Down's syndrome and normal subjects.
    McCoy EE, Enns L.
    Biochem Med; 1978 Dec 10; 20(3):385-94. PubMed ID: 156542
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The alpha adrenergic response of Down's syndrome platelets.
    Sheppard JR, Schumacher W, White JG, Jakobs KH, Schultz G.
    J Pharmacol Exp Ther; 1983 Jun 10; 225(3):584-8. PubMed ID: 6306212
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nature of lowered 5-hydroxytryptamine uptake by blood platelets of patients with Down's syndrome.
    Tukiainen E, Tuomisto J, Westermarck T, Kupiainen H.
    Acta Pharmacol Toxicol (Copenh); 1980 Nov 10; 47(5):365-70. PubMed ID: 6457503
    [Abstract] [Full Text] [Related]

  • 14. Abnormalities of calcium ion movement in platelets of patients with myeloproliferative disorders.
    Fujimoto T, Fujimura K, Kuramoto A.
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec 10; 52(8):1542-8. PubMed ID: 2629469
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 5-Hydroxytryptamine (5-HT) transport in Down's syndrome blood platelets: effect of K+ loading.
    Enns L, McCoy EE, Sneddon JN.
    Biochem Pharmacol; 1983 Jun 01; 32(11):1793-5. PubMed ID: 6223638
    [No Abstract] [Full Text] [Related]

  • 18. Decreased ATPase and increased sodium content of platelets in Down's syndrome. Relation to decreased serotonin content.
    McCoy EE, Segal DJ, Bayer SM, Strynadka KD.
    N Engl J Med; 1974 Oct 31; 291(18):950-3. PubMed ID: 4278048
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Defective binding of 5-HT by blood platelets from children with the trisomy 21 form of Down's syndrome.
    Boullin DJ, Coleman M, O'Brien RA.
    J Physiol; 1969 Oct 31; 204(2):128P+. PubMed ID: 4241928
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.